JATEUM BLACKBURN: Open Payments
NPI 1265818983 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,265 in 241 payments from 36 companies in 2025. Trend: 2023 $49,601 · 2024 $46,881 · 2025 $29,265
Speaker / faculty: $22,138Food & beverage: $4,483Travel & lodging: $2,545Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 82 | $24,902 |
| LivaNova USA, Inc. | 4 | $1,291 |
| Teva Pharmaceuticals USA, Inc. | 13 | $303 |
| PFIZER INC. | 15 | $294 |
| ARGENX US, INC. | 15 | $236 |
| Neurocrine BioSciences, Inc. | 13 | $234 |
| Neurelis, Inc. | 9 | $190 |
| Lundbeck LLC | 10 | $189 |
| ACADIA Pharmaceuticals Inc | 9 | $164 |
| UCB, Inc. | 11 | $164 |
Products named: QULIPTA, UBRELVY, VNS Therapy, VYVGART HYTRULO, INGREZZA, AUSTEDO XR, NURTEC ODT, VALTOCO.
Industry payments across TN — which companies pay providers there.
